Source: People's Daily News
On October 19th, the 10th China Innovation and Entrepreneurship Competition National Competition and hubei science and technology innovation "new species" enterprise innovation and development summit with the theme of "scientific and technological innovation and innovation, achievement of great cause" were held in Wuhan Optics Valley.
Li Meng, founder and CEO of Wuhan Xiaoyao Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Xiaoyaoyao), said in his speech as a representative of innovative enterprises that Xiaoyao pharmaceutical hopes to upgrade and empower the traditional pharmaceutical industry through digital means, improve the service capabilities of terminal pharmacies and medical institutions, and let more people enjoy better health services.
Li Meng shared her entrepreneurial original intention, the original intention of founding small medicine is to solve the pain points for the traditional medicine industry, small medicine through the innovation of "Internet smart medicine" model to innovate the circulation mode of traditional medicine layer by layer distribution, connect production enterprises and terminals together, de-intermediate, through the Empowerment of Internet technology and informatization, not only greatly improve the efficiency of the entire industry, but also ensure the safety of drug circulation.
"As a new type of digital entity enterprise with industrial Internet technology, XiaoYao Pharmaceutical hopes to reconstruct the pharmaceutical supply chain, deepen high-quality pharmaceutical services into the 'capillaries' of the motherland, and use more efficient supply chain and logistics means to enable the village doctors and ordinary people of the Enshi Tujia family to enjoy the same price and quality of drug supply as first- and second-tier cities." Li Meng said.
In the process of in-depth service to grass-roots medical institutions, small medicines have gradually found that it is far from enough to solve their drug supply problems, small medicines also need to help them solve the supply chain management, patient management and other information tools empowerment, so on the basis of pharmaceutical supply chain capabilities, small medicines have established an information solution system research and development team. At the retail pharmacy end, small medicine relies on Hainan, Wuhan and other places to establish Internet hospitals to provide online consultation services for pharmacies and patients.
In order to solve the problems of branding, clerks, and information system upgrades of single retail pharmacies, Xiaoyao Pharmaceutical has launched a smart new retail chain pharmacy brand to provide integrated smart solutions for pharmacies, providing brand empowerment, tool empowerment and business empowerment.
Li Meng believes that in the process of upgrading and developing the pharmaceutical and health industry, digital capabilities are the foundation, with the digital system to complete the system algorithm and the later service upgrade iteration, small medicines promote the deep integration of digital technology and the real economy, on the basis of building a digital system, to achieve deep and accurate algorithms, so that prescriptions, drugs, quality control and so on more safe and efficient, has an average of one million prescriptions per day processing capacity.
Li Meng said that in the future, small medicines will continue to exert efforts in scientific and technological innovation, promote the deep integration of the Internet, big data, artificial intelligence and other technologies with the real economy, empower the upgrading of the big health industry, promote digital industrialization and industrial digitalization, and help achieve the goals of digital economy and healthy China.